IFF's Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 07 2024
0mins
Source: Business Insider
- Analyst Coverage Initiation: Oppenheimer & Co. Inc. analyst initiates coverage on International Flavors & Fragrances Inc. (NYSE:IFF) with an Outperform rating and a price target of $116.
- Company Analysis: IFF aligns with consumer trends towards health and environmental consciousness, focusing on meaningful molecules.
- Portfolio Rationalization: Potential significant shift in shareholder base as the company's portfolio rationalization drives improved return on invested capital (ROIC) and strengthens the balance sheet.
- Transformation Progress: IFF progresses into the third phase of transformation with positive momentum, poised for further growth through execution and balance sheet achievements.
- Financial Estimates and Investment Opportunities: Analyst estimates adjusted EPS for FY24-FY26 and suggests exposure to IFF stock through specific ETFs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IFF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IFF
Wall Street analysts forecast IFF stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 77.510
Low
68.00
Averages
80.66
High
89.00
Current: 77.510
Low
68.00
Averages
80.66
High
89.00
About IFF
International Flavors & Fragrances Inc. is a creator and manufacturer of products for application in food, beverage, health and biosciences, scent and complementary adjacent products. Its segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Key Wall Street Rating Changes Overview
- Toll Brothers Upgrade: KBW upgraded Toll Brothers from market perform to market outperform, reflecting resilient luxury demand and improved fundamentals, which is expected to drive growth in the high-end real estate market.
- Park Aerospace Initiation: Citizens initiated coverage on Park Aerospace with a market outperform rating and a $42 price target, citing significant growth opportunities in aerospace materials, particularly in key commercial aviation engine programs.
- Apple Rating Reaffirmed: Morgan Stanley raised its price target on Apple from $330 to $360, noting that WWDC 2026 demonstrated clear progress on Apple's AI roadmap, although monetization will be a long-term endeavor.
- FuelCell Upgrade to Buy: Canaccord upgraded FuelCell from hold to buy, highlighting that the company has deployed nearly one gigawatt of energy blocks globally over the past two decades, showcasing its technology's viability and market potential.
See More
Director Paul J. Fribourg Acquires 273,500 Shares of IFF
- Director's Share Purchase: Paul J. Fribourg, a director at International Flavors & Fragrances, purchased 273,500 shares at $74.29 each for a total of $20.32 million on Monday, indicating strong confidence in the company's future, which may enhance market trust in IFF.
- Stock Price Increase: On Wednesday, IFF's stock rose approximately 2.5%, reflecting positive market reaction to Fribourg's purchase, which could attract more investor interest and further drive up the stock price.
- CEO's Investment in Aurinia: CEO Kevin Tang bought 814,606 shares of Aurinia Pharmaceuticals at $15.29 each for a total of $12.46 million on Tuesday, demonstrating optimism about Aurinia's future potential, which may boost market confidence in the company.
- AUPH Stock Performance: Aurinia Pharmaceuticals saw a 3.6% increase on Wednesday, with Tang's purchase contributing to a 4.6% rise at the day's peak, indicating optimistic market expectations for its future performance and potentially attracting more investor attention.
See More
IFF Sells Food Ingredients Business for $4.3B
- Significant Transaction: IFF has entered into an agreement to sell its food ingredients business to CVC Capital Partners for approximately $4.3 billion, reflecting a robust enterprise value-to-EBITDA multiple of about 10x, indicating strong market interest and valuation recognition for the business.
- Equity Retention for Collaboration: By retaining a 10% minority equity interest valued at around $200 million, IFF ensures ongoing collaboration with the food ingredients business, allowing both IFF and its shareholders to participate in future value creation, thereby enhancing strategic flexibility.
- Clear Use of Proceeds: IFF expects to receive approximately $3.8 billion in net cash proceeds at closing, which will be directed towards debt reduction, targeted share repurchases, and high-return opportunities within its core portfolio, optimizing capital structure and enhancing shareholder value.
- Accelerated Strategic Transformation: This transaction is viewed as a crucial milestone in IFF's portfolio optimization strategy, with CEO Erik Fyrwald stating that by simplifying the business portfolio, IFF will accelerate innovation, drive R&D investment, and more effectively integrate biotechnology and natural capabilities to address long-term trends in health and sustainability.
See More
IFF Sells Food Ingredients Business for $4.3 Billion
- Transaction Value: International Flavors & Fragrances Inc. (IFF) has signed a deal to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, with the transaction expected to close by the end of Q2 2027, marking a significant milestone in the company's portfolio optimization strategy.
- Cash Proceeds: IFF anticipates receiving around $3.8 billion in net cash proceeds from the transaction, which will be utilized to repay debt, fund share repurchases, and reinvest in high-return growth opportunities within its core portfolio, thereby enhancing financial flexibility.
- Earnings Impact: Although the sale is expected to dilute adjusted earnings per share in the first 12 months post-close, IFF plans to improve profitability through capital deployment and addressing stranded overhead costs, demonstrating confidence in future growth.
- Annual Guidance: IFF has reaffirmed its annual guidance for fiscal 2026, expecting adjusted operating EBITDA between $2.05 billion and $2.15 billion, with sales projected between $10.5 billion and $10.8 billion, indicating a stable growth outlook for its core business.
See More
IFF Sells Food Ingredients Business to Focus on High-Growth Segments
- Significant Transaction Value: IFF has entered into an agreement with CVC Capital to sell its Food Ingredients business for approximately $4.3 billion, with an EBITDA multiple of about 10x, which is expected to enhance the company's financial flexibility and shareholder value.
- Equity Retention for Collaboration: By retaining a 10% minority stake valued at around $200 million, IFF ensures continued collaboration with the Food Ingredients business while participating in future value creation, reflecting the company's confidence in the business's prospects.
- Focus on Core Businesses: This transaction marks a strategic transformation for IFF towards its innovation-driven segments—Taste, Scent, and Health & Biosciences—expected to improve cash flow characteristics and profitability, driving sustainable long-term growth.
- Planned Use of Proceeds: IFF anticipates receiving approximately $3.8 billion in net cash proceeds at closing, which will be allocated towards debt reduction, share repurchases, and reinvestment in high-return growth opportunities, although it may dilute adjusted EPS in the short term.
See More
IFF Inaugurates New Experimental Field in Grasse
- Field Inauguration: IFF's new 1.8-hectare Domaine des Naturels LMR experimental field in Grasse aims to advance research in natural ingredients by integrating traditional and modern agricultural techniques, thereby enhancing innovation and product differentiation in the fragrance industry.
- Sustainable Innovation: The field not only preserves Grasse's agricultural heritage but also promotes ecological balance through diversified water sourcing and biodiversity initiatives, allowing for real-world exploration of plant varieties and optimization of cultivation techniques to enhance agricultural system resilience.
- Education and Heritage: Domaine des Naturels LMR will gradually host the LMR Naturals Academy, offering training programs and hands-on experiences to deepen customer and perfumer understanding of sourcing and cultivating natural materials, ensuring the transmission of specialized knowledge.
- Global Network Connection: Since acquiring LMR Naturals in 2000, IFF has steadily invested in Grasse, establishing a global research network spanning Brazil, the United States, and Asia, enabling knowledge generated at Domaine des Naturels LMR to extend across IFF's 14 innovation platforms, further elevating standards in natural ingredients.
See More
Key Wall Street Rating Changes Overview
- Toll Brothers Upgrade: KBW upgraded Toll Brothers from market perform to market outperform, reflecting resilient luxury demand and improved fundamentals, which is expected to drive growth in the high-end real estate market.
- Park Aerospace Initiation: Citizens initiated coverage on Park Aerospace with a market outperform rating and a $42 price target, citing significant growth opportunities in aerospace materials, particularly in key commercial aviation engine programs.
- Apple Rating Reaffirmed: Morgan Stanley raised its price target on Apple from $330 to $360, noting that WWDC 2026 demonstrated clear progress on Apple's AI roadmap, although monetization will be a long-term endeavor.
- FuelCell Upgrade to Buy: Canaccord upgraded FuelCell from hold to buy, highlighting that the company has deployed nearly one gigawatt of energy blocks globally over the past two decades, showcasing its technology's viability and market potential.
See More
Director Paul J. Fribourg Acquires 273,500 Shares of IFF
- Director's Share Purchase: Paul J. Fribourg, a director at International Flavors & Fragrances, purchased 273,500 shares at $74.29 each for a total of $20.32 million on Monday, indicating strong confidence in the company's future, which may enhance market trust in IFF.
- Stock Price Increase: On Wednesday, IFF's stock rose approximately 2.5%, reflecting positive market reaction to Fribourg's purchase, which could attract more investor interest and further drive up the stock price.
- CEO's Investment in Aurinia: CEO Kevin Tang bought 814,606 shares of Aurinia Pharmaceuticals at $15.29 each for a total of $12.46 million on Tuesday, demonstrating optimism about Aurinia's future potential, which may boost market confidence in the company.
- AUPH Stock Performance: Aurinia Pharmaceuticals saw a 3.6% increase on Wednesday, with Tang's purchase contributing to a 4.6% rise at the day's peak, indicating optimistic market expectations for its future performance and potentially attracting more investor attention.
See More
IFF Sells Food Ingredients Business for $4.3B
- Significant Transaction: IFF has entered into an agreement to sell its food ingredients business to CVC Capital Partners for approximately $4.3 billion, reflecting a robust enterprise value-to-EBITDA multiple of about 10x, indicating strong market interest and valuation recognition for the business.
- Equity Retention for Collaboration: By retaining a 10% minority equity interest valued at around $200 million, IFF ensures ongoing collaboration with the food ingredients business, allowing both IFF and its shareholders to participate in future value creation, thereby enhancing strategic flexibility.
- Clear Use of Proceeds: IFF expects to receive approximately $3.8 billion in net cash proceeds at closing, which will be directed towards debt reduction, targeted share repurchases, and high-return opportunities within its core portfolio, optimizing capital structure and enhancing shareholder value.
- Accelerated Strategic Transformation: This transaction is viewed as a crucial milestone in IFF's portfolio optimization strategy, with CEO Erik Fyrwald stating that by simplifying the business portfolio, IFF will accelerate innovation, drive R&D investment, and more effectively integrate biotechnology and natural capabilities to address long-term trends in health and sustainability.
See More
IFF Sells Food Ingredients Business for $4.3 Billion
- Transaction Value: International Flavors & Fragrances Inc. (IFF) has signed a deal to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, with the transaction expected to close by the end of Q2 2027, marking a significant milestone in the company's portfolio optimization strategy.
- Cash Proceeds: IFF anticipates receiving around $3.8 billion in net cash proceeds from the transaction, which will be utilized to repay debt, fund share repurchases, and reinvest in high-return growth opportunities within its core portfolio, thereby enhancing financial flexibility.
- Earnings Impact: Although the sale is expected to dilute adjusted earnings per share in the first 12 months post-close, IFF plans to improve profitability through capital deployment and addressing stranded overhead costs, demonstrating confidence in future growth.
- Annual Guidance: IFF has reaffirmed its annual guidance for fiscal 2026, expecting adjusted operating EBITDA between $2.05 billion and $2.15 billion, with sales projected between $10.5 billion and $10.8 billion, indicating a stable growth outlook for its core business.
See More
IFF Sells Food Ingredients Business to Focus on High-Growth Segments
- Significant Transaction Value: IFF has entered into an agreement with CVC Capital to sell its Food Ingredients business for approximately $4.3 billion, with an EBITDA multiple of about 10x, which is expected to enhance the company's financial flexibility and shareholder value.
- Equity Retention for Collaboration: By retaining a 10% minority stake valued at around $200 million, IFF ensures continued collaboration with the Food Ingredients business while participating in future value creation, reflecting the company's confidence in the business's prospects.
- Focus on Core Businesses: This transaction marks a strategic transformation for IFF towards its innovation-driven segments—Taste, Scent, and Health & Biosciences—expected to improve cash flow characteristics and profitability, driving sustainable long-term growth.
- Planned Use of Proceeds: IFF anticipates receiving approximately $3.8 billion in net cash proceeds at closing, which will be allocated towards debt reduction, share repurchases, and reinvestment in high-return growth opportunities, although it may dilute adjusted EPS in the short term.
See More
IFF Inaugurates New Experimental Field in Grasse
- Field Inauguration: IFF's new 1.8-hectare Domaine des Naturels LMR experimental field in Grasse aims to advance research in natural ingredients by integrating traditional and modern agricultural techniques, thereby enhancing innovation and product differentiation in the fragrance industry.
- Sustainable Innovation: The field not only preserves Grasse's agricultural heritage but also promotes ecological balance through diversified water sourcing and biodiversity initiatives, allowing for real-world exploration of plant varieties and optimization of cultivation techniques to enhance agricultural system resilience.
- Education and Heritage: Domaine des Naturels LMR will gradually host the LMR Naturals Academy, offering training programs and hands-on experiences to deepen customer and perfumer understanding of sourcing and cultivating natural materials, ensuring the transmission of specialized knowledge.
- Global Network Connection: Since acquiring LMR Naturals in 2000, IFF has steadily invested in Grasse, establishing a global research network spanning Brazil, the United States, and Asia, enabling knowledge generated at Domaine des Naturels LMR to extend across IFF's 14 innovation platforms, further elevating standards in natural ingredients.
See More
